Historically, the methods of nuclear isolation for single nucleus RNA- and ATAC-sequencing have utilized buffers containing detergents that are incompatible with liquid chromatography-mass spectrometry (LC-MS), a common technique used for metabolite quantification16,17. The current protocol allows for the combination of transcriptomic and metabolomic techniques from the same sample preparation by using a gentle detergent for cellular fractionation, and following this fractionation with capillary electrophoresis, a technique that requires a smaller sample input relative to liquid chromatography for the separation of metabolites18.
The most critical aspect of this protocol is the preservation of the nuclear membrane during nuclear isolation to avoid the degradation of genetic material and reduce contamination by ambient nucleotides and macromolecules. Sample exposure times to lysis buffer can be modulated to avoid over-digestion of tissues and nuclei damage. Additionally, quick freezing of the islets during sample banking and the supernatant containing the cytosolic fraction is imperative to avoid the degradation of genetic material and metabolites. All samples must be collected from the same media formulation (2.8 mM glucose DMEM in this study) to avoid the confounding effect of altered metabolism due to nutrient availability in culture media.
A limitation of this combined metabolomic approach is that some metabolites may not be captured due to the detergent used for nuclei isolation. Therefore, for a more complete metabolite analysis, this approach could be complemented with analyses from frozen tissues and isolating metabolites using non-organic wash buffers and LC-MS. A recommended supplemental approach is targeted spatial metabolomics via MALDI-MS to localize metabolic changes within organs19. Additionally, the present technologies for evaluating transcript variability and chromatin accessibility within the same nucleus are limited due to shallow sequencing depth for ATAC sequencing. In data analyses, investigators will only be able to evaluate open chromatin regions within broad cellular clusters rather than specific subclusters within the dataset.
As the use of tissues that are not readily available, particularly those from humans and non-human primates, becomes more frequent, it is imperative to maximize the amount of information that can be extracted from a biological replicate. The multi-omic approach described above allows investigators to correlate genetic signatures with peak availability around key promotors of cellular identity while also considering how cellular metabolism may have contributed to such changes. Identifying the metabolites that are more abundant within cellular preparations will give clues to the specific epigenetic modifications that would drive the specification of cellular subtypes to a particular lineage. Indeed, new protocols have been established for integrating the findings of transcriptomic and metabolomic experiments, albeit from different tissue sources20. The significance of this protocol is that chromatin accessibility, transcriptional changes, and metabolite enrichment can be evaluated from a single sample input. Future applications of this technique will allow for better characterization of disease states in tissues acquired from sparse sample populations, such as tissues from patients with rare diseases. In the islet biology field, the characterization of gene regulatory networks and the metabolic signatures that correlate can provide critical insight as to mechanisms of preserving beta-cell identity and function to avoid the onset of diabetes.